Compound Detail
CHEMBL99946
LEVOMILNACIPRAN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL99946 |
| Name | LEVOMILNACIPRAN |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | GJJFMKBJSRMPLA-DZGCQCFKSA-N |
| Therapeutic | ✓ Yes |
5
Targets
15
Activities
2
Assay Types
7
PK Parameters
20
Publications
6
Known Names
2
Indications
Molecular Properties
246.3
MW (Da)
1.77
ALogP
2
HBA
1
HBD
46.3
PSA (Ų)
0.86
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2013 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Depressive Disorder Tobacco Use Disorder
ATC Classification
N06AX28
levomilnacipran
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOANALEPTICS
Activity Summary
IC50 13 meas. best 7.98
Ki 2 meas. best 8.07
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Sodium-dependent serotonin transporter CHEMBL313 | Ki | 8.07 | 8.07 | 8.5 | 2 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | IC50 | 7.98 | 7.5933 | 10.5 | 3 |
| Sodium-dependent serotonin transporter CHEMBL228 | IC50 | 6.5 | 5.9067 | 320.0 | 3 |
| Sodium-dependent dopamine transporter CHEMBL238 | IC50 | 5.5 | 5.5 | 3200.0 | 3 |
| Glutamate NMDA receptor CHEMBL1907608 | IC50 | 5.2 | 5.2 | 6300.0 | 4 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 566.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 5.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 5.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 24.0 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 941.75 | nM | Rattus norvegicus |
| T1/2 | 12.0 | hr | Rattus norvegicus |
| Tmax | 0.3 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine